Cargando…

Aflibercept Treatment Results and Association with Baseline Characteristics in Cases of Newly Diagnosed Neovascular Age-Related Macular Degeneration

OBJECTIVES: To evaluate functional and anatomical responses to intravitreal aflibercept (IVA) treatment in newly diagnosed and untreated neovascular age-related macular degeneration (nvAMD) cases and to investigate the effect of baseline lesion characteristics on anatomical responses. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kıyat, Pelin, Menteş, Jale, Nalçacı, Serhad, Afrashi, Filiz, Barış, Mine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251674/ https://www.ncbi.nlm.nih.gov/pubmed/34187151 http://dx.doi.org/10.4274/tjo.galenos.2020.52460

Ejemplares similares

Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration
por: Barış, Mine Esen, et al.
Publicado: (2020)

Direct Treatment Costs of Neovascular Age-related Macular Degeneration and Comparison of Gained and/or Preserved Vision with Expenditure
por: Yıldırım, Şeyda, et al.
Publicado: (2018)

Dry Eye and Meibomian Gland Dysfunction in Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Injections
por: Kıyat, Pelin, et al.
Publicado: (2022)

Vitreoretinal Interface Characteristics in Eyes with Idiopathic Macular Holes: Qualitative and Quantitative Analysis
por: Seyhan Karatepe, Arzu, et al.
Publicado: (2018)

Paracentral Acute Middle Maculopathy
por: Kıyat, Pelin, et al.
Publicado: (2020)

Characteristics of Fundus Autofluorescence in Active Polypoidal Choroidal Vasculopathy
por: Öztaş, Zafer, et al.
Publicado: (2016)

Prevalence of Polypoidal Choroidal Vasculopathy in Eyes with Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Anti-VEGF Treatment
por: Menteş, Jale, et al.
Publicado: (2022)

Multimodal Imaging of Reticular Pseudodrusen in Turkish Patients
por: Çeper, Serap Bilge, et al.
Publicado: (2023)

Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
por: Nalçacı, Serhad, et al.
Publicado: (2019)

Multimodal Imaging Characteristics of Quiescent Type 1 Neovascularization in Best Vitelliform Macular Dystrophy
por: Menteş, Jale, et al.
Publicado: (2021)

Late Closure of a Stage III Idiopathic Macular Hole after Pars Plana Vitrectomy
por: Afrashi, Filiz, et al.
Publicado: (2015)

A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination
por: Menteş, Jale, et al.
Publicado: (2023)

An Unusual Case: Self-separation of an Idiopathic Epiretinal Membrane
por: Menteş, Jale, et al.
Publicado: (2020)

Toxocara Neuroretinitis Associated with Raw Meat Consumption
por: Karaca, Irmak, et al.
Publicado: (2018)

Optical Coherence Tomography Characteristics of Quiescent Type 1 Neovascularization in Eyes with Nonexudative Age-related Macular Degeneration
por: Menteş, Jale, et al.
Publicado: (2019)

Etiological factors in young patients with Retinal Vein Occlusion
por: Nalcaci, Serhad, et al.
Publicado: (2019)

Three-dimensional Optical Coherence Tomography Imaging and Treatment of Glaucomatous Optic Nerve Head Defects Associated with Schisis-like Maculopathy
por: Öztaş, Zafer, et al.
Publicado: (2017)

Multimodal Imaging of Isolated Foveal Hypoplasia: A Case Report
por: Değirmenci, Cumali, et al.
Publicado: (2020)

Atypical Presentation of Choroidal Folds: Steroid-induced Central Serous Chorioretinopathy-like Maculopathy
por: Değirmenci, Cumali, et al.
Publicado: (2019)

The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration
por: Musiał-Kopiejka, Magdalena, et al.
Publicado: (2022)

Intravitreal Faricimab for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
por: Rush, Ryan B, et al.
Publicado: (2022)

Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
por: Ali Said, Yasmin, et al.
Publicado: (2022)

Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept
por: Sato, Tomohito, et al.
Publicado: (2021)

Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration
por: Thomas, Michael, et al.
Publicado: (2013)

Rescue effects of intravitreal aflibercept in the treatment of neovascular age-related macular degeneration
por: Hsia, Ning-Yi, et al.
Publicado: (2015)

Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
por: Garweg, Justus G
Publicado: (2019)

Monthly Alternating Injections of Aflibercept and Bevacizumab for Neovascular Age-Related Macular Degeneration
por: Lee, Junyeop, et al.
Publicado: (2022)

HIGH-DOSE HIGH-FREQUENCY AFLIBERCEPT FOR RECALCITRANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
por: You, Qi Sheng, et al.
Publicado: (2018)

Tolerating subretinal fluid in the treatment of neovascular age-related macular degeneration with intravitreal aflibercept
por: Yildiz, Dilan, et al.
Publicado: (2021)

Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review
por: Liberski, Sławomir, et al.
Publicado: (2022)

Evaluation of Choroidal Vascular Index in Amblyopic Patients
por: Furundaoturan, Onur, et al.
Publicado: (2022)

Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration
por: Gharbiya, Magda, et al.
Publicado: (2014)

Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
por: Nishikawa, Keiichi, et al.
Publicado: (2019)

Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
por: Itagaki, Kanako, et al.
Publicado: (2020)

Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
por: Marquis, Liza-Marie, et al.
Publicado: (2020)

Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
por: Razavi, Sam, et al.
Publicado: (2021)

Efficacy of Aflibercept as initial treatment for neovascular age-related macular degeneration in an Iraqi patient sample
por: Hussein, Zaid Rajab, et al.
Publicado: (2023)

One-Year Outcomes of Faricimab Treatment for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
por: Rush, Ryan B
Publicado: (2023)

IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration
por: Brand, Christopher, et al.
Publicado: (2018)

Baseline predictors for subretinal fibrosis in neovascular age-related macular degeneration
por: Roberts, Philipp K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l0l6lh4kpnbll3rr9h57i9kfcf